ADUS Stock Analysis: Buy, Sell, or Hold?
ADUS - Addus HomeCare Corp.
$115.48
-1.20 (-1.03%)
▼
5d:
+0.81%
30d:
+12.94%
90d:
+19.19%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 03, 2026
TODAY
Get Alerted When ADUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADUS is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: ADUS is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$139.50
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$86.62
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ADUS is currently trading at $115.48, which is considered extended relative to its 30-day fair value range of $102.16 to $115.44. The stock's valuation (Forward PE: 15.4) is in line with its historical norms (14.3). At these levels, the market is pricing in 2.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ADUS is in a uptrend. Immediate support is located at $109.33, while resistance sits at $120.63.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $133.00 (+15.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADUS is in a uptrend. Immediate support is located at $109.33, while resistance sits at $120.63.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $133.00 (+15.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$102.16 -
$115.44
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($133.00)
- NEUTRAL: Market pricing in 2.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$102.16 -
$115.44
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$109.33
Resistance Level
$120.63
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$133.00
(+15.2%)
Revenue Growth (YoY)
7.7%
Earnings Growth (YoY)
17.2%
Profit Margin
6.9%
Valuation Premium vs History
+2.6% premium
PE vs Historical
15.4 vs 14.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.6%
(market-implied from PE analysis)
1-Year Target
$118.48
(+3%)
2-Year Target
$121.56
(+5%)
3-Year Target
$124.72
(+8%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$115.58
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 6.9%)
$189.57
(+64%)
Base:
(SPY PE: 15.4, Growth: 6.9%)
$141.11
(+22%)
Bear:
(PE: 13.1, Growth: 6.9%)
$119.94
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 21.97 | Current EPS (TTM): $5.31
Bull Case
$180.89
(+57%)
Analyst growth 40.9%, PE expands to 24.2
Base Case
$164.45
(+42%)
Market implied 40.9%, PE stable at 22.0
Bear Case
$79.34
(-31%)
Severe decline -20.0%, PE contracts to 18.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:52 PM ET
Data refreshes hourly during market hours. Next update: 3:52 PM
Data refreshes hourly during market hours. Next update: 3:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Cliff Donald Blessing
SELL
178 shares
2026-04-21
Brian Poff
SELL
820 shares
2026-02-25
Cliff Donald Blessing
SELL
177 shares
2026-02-25
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
